Recursion Pharmaceuticals Stock (RXRX) Soars 15% on a $10M Milestone Payment from Sanofi
Recursion Pharmaceuticals stock gained nearly 15% on Thursday thanks to a drug candidate update and milestone payment.
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Pzena Investment Management Richard S. Pzena | 113,396 | $4,675,333 | +349% | 0.01% |
| 2. | Bailard Inc Thomas Bailard | 25,750 | $1,061,673 | -3% | 0.02% |
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,652,139 | $233,037,709 | 4.32% | |
| 2. | 1,990,147 | $81,798,390 | 0.41% | |
| 3. | 681,878 | $28,114,286 | 0.51% | |
| 4. | 602,300 | $24,832,829 | 1.26% | |
| 5. | 583,245 | $24,047,200 | 0.03% |